Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: TransCon PTH
Total 0 results
Nothing found
Sponsors and Collaborators
Alma Lasers Inc.
Hospital ASEPEYO Sant Cugat
Eurofins Genoma
GFI
Kupfer, David J., M.D.
Hospital Durand, Argentina
Apollo Neuroscience, Inc.
Mª Victoria Maestre Sanchez
Nacuity Pharmaceuticals, Inc.
Agency for Science, Technology and Research
RMIT University, Melbourne, Australia
Everett Meyer
Aptis Medical
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
ASST Cremona, Cremona
Korean Society of Spine Surgery
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
Neurophth Therapeutics Inc
iCAD
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
View Full List
Medical Conditions
Treatment Decisions
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
Immune-Mediated Inflammatory Disease
Gastric Cancer Stage IIIB-IIIC
Disorder of Fluid Balance
Luteal Phase Support
T-LGL Leukemia
Major Liver Surgery
Splenic Trauma
Dienogest
Corneal Cross-Linking
Fever
Metachronous Adenoma
24 Hours Esophageal PH and Multichannel Intraluminal Impedance Testing
RISS Stage III Plasma Cell Myeloma
Scleredema
Rheumatoid Arthritis(RA)
Chronic Constipation Symptoms
The Strength Properties of the Aorta in Vitro
Recurrent Clear Cell Sarcoma of Soft Tissue
View Full List
Drug Interventions
Olopatadine
OnabotulinumtoxinA
Anticholinergic
Midazolam
Capecitabine/cisplatin
Letrozole
Fospropofol disodium, propofol
Oxycodone/acetaminophen 5/325 mg
TPN-101
Intravenous Formulation of PD-0332991
RDX227675
MLN2480
Standard of care (SOC) for COVID-19
Desvenlafaxine
Camptosar
THC
Intravenous deferiprone
GLPG1837 multiple ascending doses
Capecitabine and IMRT (if randomized to this arm)
PD-1/PD-L1 inhibitor
View Full List
CROs by country
Contract Research Organizations in Burundi
Contract Research Organizations in Croatia
Contract Research Organizations in Czech Republic
Contract Research Organizations in Ecuador
Contract Research Organizations in Indonesia
Contract Research Organizations in Israel
Contract Research Organizations in Madagascar
Contract Research Organizations in Moldova
Contract Research Organizations in Qatar
Contract Research Organizations in Serbia
Contract Research Organizations in Spain
Contract Research Organizations in Taiwan
Contract Research Organizations in United States
CRO list by country
CROs in Ghana
SGS
54gene’s Clinical Programs Group (CPG)
ACROSS Global
All CROs in Ghana
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe